Loading

Journal of Cardiology and Clinical Research

Electrocardiography Diagnostic Performance for Left Ventricular Hypertrophy during Arterial Hypertension on African Cardiac Center

Research Article | Open Access | Volume 13 | Issue 1

  • 1. Department of Cardiology, Yalgado Ouédraogo University Hospital, Burkina Faso
  • 2. UFR Health Sciences, Joseph Ki Zerbo University, Burkina Faso
  • 3. Department of Cardiology, CHU Bogodogo, Burkina Faso
+ Show More - Show Less
Corresponding Authors
Ouagadougou International Polyclinic, Burkina Faso
Abstract

Introduction: Left ventricular hypertrophy (LVH) is the earliest and most common complication during hypertension. It is also a powerful predictor of cardiovascular risk. In current practice, electrocardiography (ECG), and Doppler echocardiography are the tools used for the diagnosis of LVH during arterial hypertension.

Objective: Determine the electrical diagnostic performance of LVH during arterial hypertension on African context

Methods: We conducted a descriptive and analytical cross-sectional study that took place from April 1 to July 10, 2017 in the cardiology department of the CHU/YO. Hypertensive patients were systematically included in our study. The performance of seven (07) electrical indices was evaluated by sensitivity, specificity, positive and negative predictive value and area under the curve with reference to Doppler echocardiography.

Results: 213 patients were included in the study. The sex ratio was 0.46 with a mean age of 54 years. Obesity was noted in 31% of cases and renal failure in 30% of cases. The hypertension was controlled in 39% of patients. The prevalence of hypertension on echocardiography was 22%. The electrical sensitivity of the indices ranged from 4.3% to 34.8%. Specificity ranged from 87.4% to 99.4%. PPV ranged from 28.6% to 83.3% and NPV from 78.6% to 83.8%. The MacPhie index had the best diagnostic performance with an AUC of 0.638.

Conclusion: The ECG has a poor performance in the diagnosis of LVH in hypertensive subjects. Research should focus on modeling new clues to improve the diagnostic performance of the ECG

Keywords

• Left ventricular hypertrophy

• Arterial hypertension

• Electrocardiogram

• Doppler echocardiography

Citation

LENGANI EH, KOLOGO JK, YAMEOGO AR, NACANABO WM, NEBIE LV, et al. (2025) Electrocardiography Diagnostic Performance for Left Ventricular Hypertrophy during Arterial Hypertension on African Cardiac Center. J Cardiol Clin Res. 13(1): 1210

INTRODUCTION

Hypertension is the leading risk factor for cardiovascular disease [1]. Its prevalence was estimated at 40% worldwide and 46% in Africa in 2008 [2]. The STEPS survey [2], carried out in Burkina Faso in 2013 showed a prevalence of hypertension of 18%, with 25% in urban areas and 15% in rural areas.

High blood pressure is associated with a number of complications, including left ventricular hypertrophy (LVH), the earliest and most common. It is considered a powerful independent predictor of cardiovascular risk [3 5]. Occasional studies show a higher prevalence in black subjects compared with Caucasians [6]. The prevalence of LVH was 32% in Nigeria in 2013 [7], and 62% in Cameroon in 2014 [8]. In Burkina Faso, Niakara [9], found a prevalence of 53.3% in 2001 in urban areas and Yaméogo [10], a prevalence of 44.4% in rural areas in 2014.

Several methods are used to diagnose LVH in hypertension. These include chest X-ray, ECG, Doppler echocardiography, chest CT scan and MRI. In our context, the ECG is the most widely used diagnostic tool because it is the most affordable. Numerous electrical criteria and scores have been developed for the diagnosis of LVH; However, their diagnostic performance remains highly variable due to the interaction of certain factors such as age, gender, obesity and the presence of a metabolic syndrome [11,12]. Doppler echocardiography is highly sensitive and specific, making it the gold standard for diagnosing LVH [13].

In view of the paucity of studies carried out in Africa on the diagnostic performance of ECG in the diagnosis of LVH during hypertension and the particularity of black subjects, we asked ourselves the following question: are scores and indices effective in the diagnosis of LVH? The aim of this study was therefore to evaluate the diagnostic performance of the various electrical scores and indices, using Doppler echocardiography as the gold standard.

 

METHODOLOGY

The study took place in the cardiology department of CHU Yalgado OUEDRAOGO from 1 April to 10 July 2017. This was a descriptive and analytical cross-sectional study with a diagnostic aim.

Patients with hypertension were included in the study, regardless of age, sex with or without other cardiovascular risk factors and who had received at least one cardiology consultation. Only patients who agreed to take part in the study were included after informed consent

ECG: patients with rhythm disorders such as atrial flutter, complete arrhythmia due to atrial fibrillation, pre excitation syndrome, and conduction disorders such as BAV II or III were excluded from our study;

On Doppler echocardiography: the presence of a septal bulge, asymmetric septal hypertrophy, a paradoxical septum and very hypoechoic patients were excluded.

The following indices have been used to diagnose electrical LVH [14]:

- Sokolow-Lyon index: R in V5 or V6 + S in V1 > 35 mm;

- Sokolow-Lyon product: (RV5 or RV6 + SV1) × QRS duration > 3000 mm.ms in women and 4000 mm.ms in men

- Cornell index: RaVL+SV3 > 20 mm in women and 24 mm in men;

- Cornell product: (RaVL+SV3+8) × QRS duration > 2440 mm.ms in women and (RaVL+SV3) × QRS duration > 2440 mm.ms in men;

- Gubner index: RDI+SDIII > 25 mm;

- Lewis number: (RDI+SDIII)-(SDI+RDIII)>17 mm;

- MacPhie index: Rmax+Smax> 40 mm.

On Doppler echocardiography, LVH was considered for the following threshold values [15]: left ventricular mass (LVM) indexed to body surface area greater than 110 g/m2 in women and 134 g/m2 in men.

The data were analysed using R software [16], and the pROC package [17], was used for AUC analysis and comparison. Diagnostic performance was defined for each ECG index by calculating sensitivity (Sen), specificity (Spe), positive predictive value (PPV), negative predictive value (NPV) and AUC. AUC was compared using Delong’s test. Tests were statistically significant if p ? 0.05.

RESULTS

General data

We included 213 hypertensive patients over our study period. The sex ratio was 0.46 with a female frequency of 68.5% (n = 146). The mean age of the study population was 54 ±12 years, with extremes of 23 and 79 years. Patients with hypertension for more than five years accounted for 56% (n = 119) of the subjects. The general characteristics of the population are listed in Table 1.

Table 1: General characteristics of patients (n = 213

Characteristics

Values

Sociodemographic caracterises

Average age (years)

54 ± 12 years

Female

146 (68,5 %)

HTA duration

 

HTA more than 5 years

119 (56%)

HTA between 1-5 years

60 (28%)

HTA less than 1 ans

34 (16%)

Facteurs de risque cardiovasculaire

 

Sedentarity

163 (76,5 %)

Obesity

66 (31%)

Dyslipidemia

57 (26,7%)

Diabetes

31 (14,6%)

Smoking

9 (4,2%)

Level of Hypertension

Controled

83 (39%)

HTA grade I

69 (32,4%)

HTA grade II

37 (17,3%)

HTA grade III

24 (11,3%)

Retentissement HTA

Kidney chronic faillure

65 (30,5%)

Hypertension rethinopathy

47 (22%)

Stroke

27 (12,6%)

Electrical and echocardiographic data

On electrocardiogram, the prevalence of left ventricular hypertrophy according to the Lewis index was the highest (n = 31, 15%). A repolarisation disorder was found in 24% (n=51) of cases and subepicardial ischaemia was the most frequent disorder. Echocardiography Left ventricular hypertrophy indexed to body surface area was found in 22% (n=46) of patients. Concentric remodelling was found in 33% (n = 71) of cases. The patients’ electrical and echocardiographic data are listed in Table 2.

Table 2: Electrocardiogram and Doppler Cardiac ultrasound data

Parameters

Values

Electrocardiogram

Prevalence of left ventricle hypertrophy depending on the index

Lewis index

31 (15%)

Cornell index

28 (13%)

MacPhie index

28 (13%)

Cornell Product

26 (12%)

Sokolow-Lyon index

18 (8,5%)

Gubner index

7 (3,3%)

Sokolow-Lyon product

6 (3%)

Repolarisation abnomalities (n=51) n (%)

Ischemia under epicardial

31 (61%)

Ischemia under endocardial

13 (25%)

Endocardial lesion

7 (14%)

Doppler cardiac ultrasound

Prevalence of left ventricle hypertrophy

46 (22%)

Left ventricle geometry n (%)

 

Normal

61 (29%)

Concentric remodeling

71 (33%)

Concentric hypertension

61 (29%)

Excentric hypertrophy

20 (9%)

Average of ejection fraction of the left ventricle

63% ± 7,93%

Diastolic fonction of the left ventricle

 

Normal

96 (46%)

Abnomalites of relaxation

107 (51%)

Restrictif profil

7 (3%)

Diagnostic performance of the ECG

The MacPhie index had the best intrinsic performance with a sensitivity of 35% and a specificity of 93%. It also had the best extrinsic performance with a positive predictive value of 57% and a negative predictive value of 84%. Table 3

Table 3: Diagnostic performance of electrocardiogram for ventricular hypertrophy

Criteries

Sen

Spe

VPP

VPN

ASC (Intervalle de

confiance à 95%)

MacPhie index

34,8

92,8

57,1

83,8

0,638 (0,54 – 0,74)

Cornell index

32,6

92,2

53,6

83,2

0,624 (0,52 – 0,72)

Cornell product

28,3

92,2

50

82,3

0,602 (0,50 – 0,70)

Sokolow-Lyon index

21

95

55

81

0,585 (0,48 – 0,68)

Sokolow-Lyon product

10

99,4

83,3

80,1

0,551 (0,45 – 0,65)

Lewis index

21,7

87,4

32,2

80,2

0,546 (0,45 – 0,64)

Gubner index

4,3

97

28,6

78,6

0,507 (0,41 – 0,60)

summarises the diagnostic performance of the various electrical indices and Figure 1

Figure 1:ROC curve of diagnosis performance of MacPhie index, AUC: Area under the curve

shows the AUC of the MacPhie index.

Table 4

Table 4: Electrical performance depending on obesity

 

Indix

SC (IC à 95%)

Test of Delong (P-value)

Obesity

unobesity

 

Cornell index

0,682 (0,54 - 0,81)

0,687 (0,53 - 0,83)

0,9575

MacPhie index

0,724 (0,58 - 0,86)

0,692 (0,55 - 0,83)

0,7519

Sokolow-Lyon index

0,617 (0,41- 0,81)

0,739 (0,58 - 0,89)

0,3468

shows the performance of the best electrical indices as a function of obesity. We note a discrepancy between the results, although the statistical tests are not significant. The Cornell Index was practically unaffected by obesity

The binomial association of the Cornell index and secondary repolarization disorder significantly increased electrical diagnostic performance with an area under the curve of 0.805. Figure 2

Figure 2:ASC of the association of the Cornelle index and the secondary repolarization disorder, ASC: area under the curve

shows the AUC plot for the combination of Cornell Index and secondary repolarisation disorder.

DISCUSSION

The diagnostic prevalence of left ventricular hypertrophy by electrocardiogram, all indices combined, varied between 3 and 15% in our study. This low prevalence was reported by Verdecchia [18], who also found a prevalence between 3.9 and 17.8%. This variability in the electrical prevalence of LV hypertrophy may be due to the existence of a wide variety of ECG indices and criteria for diagnosing LVH.

Electrical sensitivity for all criteria combined ranged from 4.3% to 34.8% in our study. Our data are much lower than those in the literature, which show a higher sensitivity of the electrical tool in the diagnosis of LVH. Indeed, Ogulandé [19], in Nigeria found a sensitivity varying between 13.8 and 58.6% but reported that the Gubner index had the lowest performance. The specificity found in our study varied between 87.4 and 99.4%. This high specificity of electrocardiography for the diagnosis of left ventricular hypertrophy had been described by Niakara [20], in 2001 who found a specificity between 72 and 89% and Gaspérin [21], in Brazil who reported a specificity between 76 and 93.6%. Overall, our study agrees with the literature that the ECG has poor sensitivity and high specificity in the diagnosis of LVH [22].

The PPV found in our study varied from 28.6 to 83.3%. The Sokolow-Lyon index had the best PPV. Gaspérin [21], also reported that the Sokolow-Lyon index had the best positive predictive value at 57.58%. The NPV in our study ranged from 78.6% to 83.8%. Our results are similar to those of Dada [23], and Ogulandé [19], in Nigeria, who found very high NPVs ranging from 81 to 90.29% and 67.9 to 76.3% respectively.

The AUC of the conventional indices in our study ranged from 0.507 to 0.638. The MacPhie index had the best diagnostic performance in the study population, followed by the Cornell index and the Cornell product. All indices had a poor ability to diagnose LVH. The best indices were influenced by obesity, apart from the Cornell index, although statistical tests were not significant. Okin [24], also showed in his study that the Cornell index and the Cornell product were the indices least influenced by patient morphology. Niakara [20], and de Tsiachris [13], had also shown that the Cornell index and the Cornell product had the best electrical performance in the diagnosis of LVH in hypertensive patients, regardless of their build. In our study, the combination of the Cornell index and secondary repolarisation disorder had better diagnostic performance than conventional indices. Indeed, Ehara [25], found that the presence of secondary repolarisation disorder alone had a higher sensitivity and specificity than the Sokolow-Lyon index in the diagnosis of LVH in hypertensive subjects. However, the number of patients with a secondary repolarisation disorder was low in our study, so it is not possible to confirm the performance of this association.

CONCLUSION

The ECG is the most widely used diagnostic tool for assessing the cardiac impact of hypertension. However, it is accredited with poor performance in the diagnosis of LVH in hypertension. The electrical criteria currently used routinely have good specificity, but very low sensitivity. Combining conventional indices with a parameter such as the presence of a secondary repolarisation disorder greatly improves the diagnostic performance of the ECG for LVH. Research using larger studies should be encouraged in order to find more effective and practical electrical criteria.

RÉFÉRENCES
  1. Bryan W, Guiseppe M, Wilko S, Enrico AR, Michel A, Michel B, et al. ESC/ESH Guidelines for the Management of arterial hypertension. Eur Heart J. 2018; 39: 3021-3104.
  2. Soubeiga JK, Millogo T, Bicaba BW, Doulougou B, Kouanda S. Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study. BMC Public Health. 2017 ; 17: 64.
  3. Cuspidi C, Esposito A, Negri F, Sala C, Masaidi M, Giudici V, et al. Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension : Un message clair pour le clinicien ? Am J Hypertens. 2008 ; 21: 458-463.
  4. Kamath S, Markham D, Drazner MH. Increased prevalence of concentric left ventricular hypertrophy in African-Americans : Une épidémie d’insuffisance cardiaque s’ensuivra-t-elle ? Heart Fail Rev. 2006 ; 11: 271-277.
  5. Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, et al. Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population ? J Clin Hypertens. 2016; 18: 415-421.
  6. Abassade P, Lamour P, Iung B, Delbechi G, Guiomard A. Left ventricular hypertrophy in patients with hypertension. Une étude comparative entre les Africains noirs et les Européens blancs. Ann Cardiol Angeiol. 1996; 45: 567-572.
  7. Nkado RN, Onwubere BJC, Ikeh VO, Anisiuba BC. Correlation of Electrocardiogram with Echocardiographic left ventricular mass in adult Nigerians with systemic hypertension. West Afr J Med. 2003; 22: 246-249.
  8. Jingi AM, Noubiap JJN, Kamdem P, Kingue S. Déterminants et amélioration du diagnostic électrocardiographique de l’hypertrophie ventriculaire gauche dans une population d’Afrique noire. PLOS ONE. 2014 ; 9: e96783.
  9. Niakara A, Ouédraogo N, Nébié LVA, Samadoulougou AK, Kaboré NJP, Ouandaogo BJ. L’hypertrophie ventriculaire gauche du Noir Africain hypertendu : étude échocardiographique chez 452 sujets. Ann Cardiol Angeiol. 2001; 50: 197-201.
  10. Yaméogo C. Hypertension artérielle, Hypertrophie ventriculaire gauche et risque. Mémoire DES cardio. Université de Ouagadougou. 2015; 95.
  11. Cuspidi C, Rescaldani M, Sala C, Guido G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014; 32: 16-25.
  12. HouénassiD, Tchabi Y, Awanou B, Véhounkpé-Sacca J, Akindès- Dossou YR, Sehonou F, et al. Évolution du risque cardiovasculaire des patients traités pour HTA à l’hôpital d’instruction des armées de Cotonou. Ann CardiolAngeiol. 2013; 62: 12-16.
  13. Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, et al. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria S. J Hypertens. 2011; 29: 1624-1632.
  14. Lu N, Zhu JX, Yang PX, Tan XR. Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria. BMC Cardiovasc Disord. 2017 ; 17: 217.
  15. Cohen A, Guéret P, Abergel E, Brochet E, Derumeaux G, Roudaut R. Manuel d’échocardiographie Clinique.ed LAVOISIER : 543-557. Paris. 2012.
  16. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12: 77
  17. R Development Core Team. R: un langage et un environnement pour le calcul statistique. R Foundation for Statistical Computing, Vienne, Autriche. 2005.
  18. Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension : the MAVI study. J Am Coll Cardiol. 2001; 38: 1829-1835.
  19. Ogunlade O, Akintomide AO. Évaluation des critères de tension pour l’hypertrophie ventriculaire gauche chez les hypertendus adultes dans le sud-ouest du Nigeria. J Cardiovasc Dis Res. 2013; 4: 44-46.
  20. Niakara A, Ouédraogo N, Nébié LVA, Kaboré NPJ, Megnigbeto CA. Indices électrocardiographiques de routine pour le diagnostic de l’hypertrophie ventriculaire gauche : performances chez le sujet noir africain. Ann CardiolAngeiol. 2002; 51: 193-198.
  21. Gasperin CA, Germiniani H, Facin CR, Moares de Souza A, Pereira Da Cunha CL. Une analyse des critères électrocardiographiques pour déterminer l’hypertrophie ventriculaire gauche. Arq Bras Cardiol. 2002; 78: 59-82.
  22. Martin TC, Bhaskar YG, Umesh KV. Sensibilité et spécificité de l’électrocardiogramme pour prédire la présence d’une augmentation de l’indice de masse ventriculaire gauche sur l’échocardiogramme chez les patients hypertendus afro-caribéens. West Indian Med J. 2007; 56: 134-138.
  23. Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO. Comparaison des critères d’Araoye avec les critères électrocardiographiques standard pour le diagnostic de l’hypertrophie ventriculaire gauche chez les hypertendus nigérians. West Afr J Med. 2006; 25: 179-185.
  24. Okin PM, Roman MJ, Devereux RB, Kligfield P. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus. J Electrocardiol. 1996; 29: 256-261.
  25. Ehara S, Hasegawa T, Matsumoto K, Otsuka K, Yamazaki T, Iguchi T, et al. The strain pattern, and not Sokolow-Lyon electrocardiographic voltage criteria, is independently associated with anatomic left ventricular hypertrophy. Heart Vessels. 2014; 29: 638-644.

LENGANI EH, KOLOGO JK, YAMEOGO AR, NACANABO WM, NEBIE LV, et al. (2025) Electrocardiography Diagnostic Performance for Left Ventricular Hypertrophy during Arterial Hypertension on African Cardiac Center. J Cardiol Clin Res. 13(1): 1210.

Received : 14 Feb 2025
Accepted : 20 Mar 2025
Published : 24 Mar 2025
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X